Replies to post #13976 on Momenta Pharmaceuticals, Inc. (MNTA)

[imnot6]

Aetna Glatopa Coverage Policy

Multiple Sclerosis policy - II.Outpatient Treatment - B Relapsing, remitting... - 7. Glatiramer acetate

(cf same text noted in Review History Link>Revisions>9/9/2015)

"Glatopa brand of glatiramer acetate is less costly to Aetna than Copaxone brand of glatiramer acetate, and is likely to produce equivalent therapeutic results. Therefore, Copaxone will be considered medically necessary only if the member has a contraindication, allergy, intolerance, or failure of an adequate trial of Glatopa."